Annual Cash & Cash Equivalents
$47.94 M
-$20.50 M-29.95%
December 31, 2022
Summary
- As of February 8, 2025, EVLO annual cash & cash equivalents is $47.94 million, with the most recent change of -$20.50 million (-29.95%) on December 31, 2022.
- During the last 3 years, EVLO annual cash & cash equivalents has fallen by -$29.89 million (-38.41%).
- EVLO annual cash & cash equivalents is now -48.51% below its all-time high of $93.10 million, reached on December 31, 2018.
Performance
EVLO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$17.26 M
+$9.64 M+126.48%
September 30, 2023
Summary
- As of February 8, 2025, EVLO quarterly cash and cash equivalents is $17.26 million, with the most recent change of +$9.64 million (+126.48%) on September 30, 2023.
- Over the past year, EVLO quarterly cash and cash equivalents has dropped by -$51.79 million (-75.00%).
- EVLO quarterly cash and cash equivalents is now -90.35% below its all-time high of $178.90 million, reached on June 30, 2018.
Performance
EVLO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
EVLO Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.9% | -75.0% |
| 3 y3 years | -38.4% | -78.8% |
| 5 y5 years | +25.4% | -78.3% |
EVLO Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -29.9% | at low | -81.2% | +126.5% |
| 5 y | 5-year | -38.4% | at low | -86.2% | +126.5% |
| alltime | all time | -48.5% | +208.6% | -90.3% | +126.5% |
Evelo Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $17.26 M(+126.5%) |
| Jun 2023 | - | $7.62 M(-72.3%) |
| Mar 2023 | - | $27.47 M(-42.7%) |
| Dec 2022 | $47.94 M(-30.0%) | $47.94 M(-30.6%) |
| Sep 2022 | - | $69.05 M(-24.9%) |
| Jun 2022 | - | $92.01 M(+132.2%) |
| Mar 2022 | - | $39.63 M(-42.1%) |
| Dec 2021 | $68.44 M(-0.6%) | $68.44 M(-28.7%) |
| Sep 2021 | - | $95.94 M(-22.2%) |
| Jun 2021 | - | $123.33 M(-1.0%) |
| Mar 2021 | - | $124.59 M(+80.9%) |
| Dec 2020 | $68.86 M | $68.86 M(-15.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $81.58 M(-9.5%) |
| Jun 2020 | - | $90.17 M(+55.2%) |
| Mar 2020 | - | $58.12 M(-25.3%) |
| Dec 2019 | $77.83 M(-16.4%) | $77.83 M(-19.8%) |
| Sep 2019 | - | $97.06 M(-11.3%) |
| Jun 2019 | - | $109.47 M(+3.8%) |
| Mar 2019 | - | $105.49 M(+13.3%) |
| Dec 2018 | $93.10 M(+143.4%) | $93.10 M(+16.8%) |
| Sep 2018 | - | $79.71 M(-55.4%) |
| Jun 2018 | - | $178.90 M(+56.5%) |
| Mar 2018 | - | $114.31 M(+198.9%) |
| Dec 2017 | $38.25 M(+146.2%) | $38.25 M |
| Dec 2016 | $15.54 M | - |
FAQ
- What is Evelo Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Evelo Biosciences?
- What is Evelo Biosciences annual cash & cash equivalents year-on-year change?
- What is Evelo Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Evelo Biosciences?
- What is Evelo Biosciences quarterly cash and cash equivalents year-on-year change?
What is Evelo Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of EVLO is $47.94 M
What is the all time high annual cash & cash equivalents for Evelo Biosciences?
Evelo Biosciences all-time high annual cash & cash equivalents is $93.10 M
What is Evelo Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, EVLO annual cash & cash equivalents has changed by -$20.50 M (-29.95%)
What is Evelo Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of EVLO is $17.26 M
What is the all time high quarterly cash and cash equivalents for Evelo Biosciences?
Evelo Biosciences all-time high quarterly cash and cash equivalents is $178.90 M
What is Evelo Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, EVLO quarterly cash and cash equivalents has changed by -$51.79 M (-75.00%)